BMC Cancer

1. ZHANG W, Hou Z, Zhang L, Hong X, et al
   A log odds of positive lymph nodes-based predictive model effectively forecasts prognosis and guides postoperative adjuvant chemotherapy duration in stage III colon cancer: a multi-center retrospective cohort study.
   BMC Cancer. 2024;24:1088.
   

   >> Share

   
   
2. CHENG Y, Teng Z, Zhang Y, Jin B, et al
   Irinotecan plus raltitrexed as second-line treatment in locally advanced or metastatic colorectal cancer patients: a prospective open-label, single-arm, multi-center, phase II study.
   BMC Cancer. 2024;24:1082.
   

   >> Share

   
   
3. OUYANG Z, Chen P, Zhang M, Wu S, et al
   Arginine on immune function and post-operative obstructions in colorectal cancer patients: a meta-analysis.
   BMC Cancer. 2024;24:1089.
   

   >> Share

   
   
4. TONGOL E, Kang P, Cheng V, Gastonguay L, et al
   What are the experiences of colorectal cancer patients with biomarker testing in Canada?: a mixed methods study.
   BMC Cancer. 2024;24:1076.
   

   >> Share

   
   

   
   BMC Gastroenterol

5. YU J, Yang H, Zhang L, Ran S, et al
   Correction: Effect and potential mechanism of oncometabolite succinate promotes distant metastasis of colorectal cancer by activating STAT3.
   BMC Gastroenterol. 2024;24:297.
   

   >> Share

   
   

   
   Br J Cancer

6. CHOWDHURY S, Xiu J, Ribeiro JR, Nicolaides T, et al
   Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumors.
   Br J Cancer. 2024 Sep 4. doi: 10.1038/s41416-024-02826.
   

   >> Share

   
   

   
   Br J Surg

7. ZUKAUSKAITE K, Horvath A, Gricius Z, Kvietkauskas M, et al
   Impact of mechanical bowel preparation on the gut microbiome of patients undergoing left-sided colorectal cancer surgery: randomized clinical trial.
   Br J Surg. 2024;111:znae213.
   

   >> Share

   
   

   
   Cancer Lett

8. YANG H, Gong C, Wu Y, Xie X, et al
   LncRNA SNHG1 facilitates colorectal cancer cells metastasis by recruiting HNRNPD protein to stabilize SERPINA3 mRNA.
   Cancer Lett. 2024 Sep 2:217217. doi: 10.1016/j.canlet.2024.217217.
   

   >> Share

   
   

   
   Cancer Res

9. CHEN D, Ji F, Zhou Q, Cheung H, et al
   RUVBL1/2 Blockade Targets YTHDF1 Activity to Suppress m6A-Dependent Oncogenic Translation and Colorectal Tumorigenesis.
   Cancer Res. 2024;84:2856-2872.
   

   >> Share

   
   
10. SHU Y, Jin X, Ji M, Zhang Z, et al
    Ku70 Binding to YAP Alters PARP1 Ubiquitination to Regulate Genome Stability and Tumorigenesis.
    Cancer Res. 2024;84:2836-2855.
    

    >> Share

    
    

    
    Dis Colon Rectum

11. WEAVER L, Goffredo P
    Neoadjuvant Therapy for Colon Cancer.
    Dis Colon Rectum. 2024 Sep 4. doi: 10.1097/DCR.0000000000003524.
    

    >> Share

    
    
12. SIMIANU VV
    Expert Review on Neoadjuvant Therapy for Colon Cancer.
    Dis Colon Rectum. 2024 Sep 4. doi: 10.1097/DCR.0000000000003525.
    

    >> Share

    
    

    
    Eur J Cancer

13. AMBROSINI M, Tougeron D, Modest D, Guimbaud R, et al
    BRAF + EGFR +/- MEK inhibitors after immune checkpoint inhibitors in BRAF V600E mutated and deficient mismatch repair or microsatellite instability high metastatic colorectal cancer.
    Eur J Cancer. 2024;210:114290.
    

    >> Share

    
    

    
    Gastroenterology

14. CARVALHO B, de Klaver W, van Wifferen F, van Lanschot MCJ, et al
    Stool-based testing for post-polypectomy colorectal cancer surveillance safely reduces colonoscopies: The MOCCAS study.
    Gastroenterology. 2024 Aug 28:S0016-5085(24)05402.
    

    >> Share

    
    
15. DAS AK, Eagle C, Talasaz A
    Correspondence on "Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage Decision".
    Gastroenterology. 2024 Aug 29:S0016-5085(24)05410.
    

    >> Share

    
    
16. AZIZ Z, Rustgi S, Hur C
    Response to Recently Published Cost Effectiveness Analyses on Liquid Biopsy for Colorectal Cancer Screening.
    Gastroenterology. 2024 Aug 29:S0016-5085(24)05408.
    

    >> Share

    
    

    
    Int J Cancer

17. LONARE A, Raychaudhuri K, Shah S, Madhu G, et al
    14-3-3sigma restricts YY1 to the cytoplasm, promoting therapy resistance, and tumor progression in colorectal cancer.
    Int J Cancer. 2024 Sep 6. doi: 10.1002/ijc.35176.
    

    >> Share

    
    

    
    Int J Colorectal Dis

18. SVERRISSON I, Smedh K, Chabok A, Nikberg M, et al
    The risk for rectal cancer recurrence and overall mortality is not increased in men previously diagnosed with prostate cancer: a report from the Swedish colorectal cancer registry.
    Int J Colorectal Dis. 2024;39:137.
    

    >> Share

    
    

    
    Int J Oncol

19. TONG G, Shen Y, Li H, Qian H, et al
    NLRC4, inflammation and colorectal cancer (Review).
    Int J Oncol. 2024;65:99.
    

    >> Share

    
    

    
    J Clin Oncol

20. CHIBAUDEL B, Raeisi M, Cohen R, Yothers G, et al
    Assessment of the Addition of Oxaliplatin to Fluoropyrimidine-Based Adjuvant Chemotherapy in Patients With High-Risk Stage II Colon Cancer: An ACCENT Pooled Analysis.
    J Clin Oncol. 2024 Sep 4:JCO2400394. doi: 10.1200/JCO.24.00394.
    

    >> Share

    
    

    
    J Natl Cancer Inst

21. DESHMUKH AA, Lin YY, Damgacioglu H, Shiels M, et al
    Recent and projected incidence trends and risk of anal cancer among people with HIV in North America.
    J Natl Cancer Inst. 2024;116:1450-1458.
    

    >> Share

    
    
22. GARG A, Damgacioglu H, Sigel K, Nyitray AG, et al
    Future patterns in burden and incidence of squamous cell carcinoma of the anus in the United States, 2001-2035.
    J Natl Cancer Inst. 2024;116:1508-1512.
    

    >> Share

    
    

    
    J Pathol

23. AZIMI M, Cho S, Bozkurt E, McDonough E, et al
    Spatial effects of infiltrating T cells on neighbouring cancer cells and prognosis in stage III CRC patients.
    J Pathol. 2024;264:148-159.
    

    >> Share

    
    

    
    J Surg Oncol

24. RAY-OFFOR E, Garoufalia Z, Emile SH, Horesh N, et al
    Heterogeneity in survival within age groups of early-onset colorectal cancer patients: A National Cancer Database analysis.
    J Surg Oncol. 2024 Sep 5. doi: 10.1002/jso.27754.
    

    >> Share

    
    

    
    Oncology

25. DIMBERG J, Shamoun L, Af Geijerstam K, Landerholm K, et al
    Significance of Gene Polymorphism and Gene Expression of BACE2 in Swedish Patients with Colorectal Cancer.
    Oncology. 2024 Aug 14:1-8. doi: 10.1159/000540887.
    

    >> Share

    
    

    
    PLoS One

26. OGUNDIPE O, Kurt Z, Woo WL
    Deep neural networks integrating genomics and histopathological images for predicting stages and survival time-to-event in colon cancer.
    PLoS One. 2024;19:e0305268.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

27. ZHANG N, Zhang R, Jiang L, Gao Z, et al
    Inhibition of colorectal cancer in Alzheimer's disease is mediated by gut microbiota via induction of inflammatory tolerance.
    Proc Natl Acad Sci U S A. 2024;121:e2314337121.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share